DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $638,000 | – | 38,152 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
| Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
| EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
| RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
| Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
| Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
| Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
| Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
| Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |